Summary
Platelet-activating factor (PAF), a potent phospholipid inflammatory mediator, known to affect cellular phosphoinositide metabolism, through formation of inositol triphosphate, transiently releases intracellular calcium. This highly sensitive cellular signaling process is involved in a great variety of cellular responses in many organs, and it may play a pivotal role in regulating meditor release in the cell. Through activating phospholipase A2, leading to arachidonic acid release and eicosanoid generation, PAF may induce downregulation of mediator release, an important process to maintain normal cell metabolism. On the other hand, via interacting with various cytokines or bacterial lipopolysaccharides, PAF may up-regulate mediator release, initiating an important role for the phospholipid noy only under normal conditions, but also in pathophysiological alterations of cellular responses and metabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abigail, F., Brotherton, A., and Hoack, J.C. (1982). Role of Ca2+ and cyclic AMP in the regulation of the production of prostacyclin by the vascular endothelium. Proc. Natl. Acad. Sci. USA 79: 495–499.
Aepfelbacher, M., Ziegler-Heitbrock, H.W., Lux, I., and Weber, P.C. (1992). Bacterial lipopolysaccharide up-regulates platelet-activating factor stimulated Ca2+ mobilization and eicosanoid release in human Mono Mac 6 cells. J. Immunol. 148: 2186–2193.
Berridge, M.J. (1993a). Inositol triphosphate and calcium signalling. Nature 361: 315–325.
Berridge, M.J. (1993b). A tale of two messengers. Nature 365: 388–389.
Billah M.M. anf Lapetina, E.G. (1983). Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: Possible relationship to Ca2+ mobilization during stimulation. Proc. Natl. Acad. Sci. USA 80: 965–968.
Billah, M.M. and Siegel, M.I. (1984). Calmodulin antagonists inhibit formation of plateletactivating factor in stimulated human neutrophils. Biochem. Biophys. Res. Commun. 118: 629–635.
Bito, H., Nakamura, M., Honda, Z., Izumi, T., Iwatsubo, T., Seyama, Y., Ogura, A., Kudo, V., and Shimizu, T. (1992). Platelet-activating factor (PAF) receptor in rat brain: PAF metabolizes intracellular Ca2+ in hippocampal neurons. Neuron 9: 285–294.
Braquet, P., Hosford, D., Koltz, P., Gilbaud, J., and Paubert-Braquet, M. (1990). Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins. Lipids 26: 1071–1074.
Braquet, P., Paubert-Braquet, M., Bourgain, R., Bussolino, F., and Hosford, D. (1989a) PAF/cytokine autogenerated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. J. Lipid Med. 1: 75–112.
Braquet, P., Paubert-Braquet, M., Koltai, M., Bourgain, R., Bussolino, F., and Hosford. D. (1989b). Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol. Sci. 10: 23–30.
Braquet, P., Touqui, L., Shen, T.S., and Vargaftig, B.B. (1987). Perspectives in plateletactivating factor research. Pharmacol. Rev. 39: 97–145.
Catalan, R.E., Martinez, A.M., Aragones, M.D., Fernandez, I., Lombardia, M., and Miguel, E.G. (1992). PAF-induced activation of polyphosphoinositide-hydrolyzing phospholipase C in cerebral cortex. Biochem. Biophys. Res. Commun. 183: 300–305.
Chiba, Y., Mikoda, N., Kawasaki, H., and Ito, K. (1990). Endothelium-dependent relaxant action of platelet activating factor in the rat mesenteric artery. Naunyn-Schmiedeberg’s Archs Pharmacol. 341: 68–73.
Clark, G.D., Happel, L.T., Zorumski, C.F., and Bazan, N.G. (1992). Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9: 1211–1216.
Clement, M.G., Albertini, M., Dimori, M., and Aguggini, G. (1992). PAF and the role of vagus nerve in the breathing pattern of the pig. Prostagl. Leuk. Essent. Fatty Acids 45: 143–149,
Collins, S. (1993). Molecular structure of G-protein-coupled receptors and regulation of their expression. DN&P 6: 480–487.
Conrad, G.W. and Rink, T.J. (1986). Platelet-activating factor raises intracellular calcium ion concentration in macrophages. J. Cell Biol. 103: 439–450.
Edwards, G. and Weston, A.H. (1993). The pharmacology of ATP-sensitive K-channels. Annu. Rev. Pharmacol. Toxicol. 33: 597–637.
Forstermann, U., Pollock, J.S., Schmidt, H.H.H.W., Heller, M., and Murad, F. (1991). Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88: 1788–1792.
Gorman, R.R., Bunting, S., and Miller, O.V. (1977). Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377–388.
Hall, LP. (1993). Inositol phosphates, cyclic AMP and signal transduction. DN&P 6: 5– 11.
Hanahan, D.J., Demopoulos, C.A., Liehr, J., and Pinckard, R.N. (1980). Identification of platelet-activating factor isolated from rabbit J. Biol. Chem. 255: 5514–5516.
Harnett, M.M. and Klaus, G.G.B. (1988). G protein coupling of antigen receptorstimulated phosphatidylinositol hydrolysis in B cells. J. Immunol. 140: 3135–3139.
Homma, H. and Hanahan, D.J. (1988). Attenuation of platelet-activating factor (PAF)-induced stimulation of rabbit GTPase by phorbol ester, dibutyryl cAMP,and desensitization: concomitant effects on PAF receptor binding charecteristics. Arch. Biochem. Biophys. 262: 32–39.
Hwang, S.-B. and Lim, M.-H. (1986). Ionic and GTP regulation of binding of plateletactivating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. J. Biol. Chem. 261: 532–537.
Kamata, K., Mori, T., Shigenobu, K., and Kasuya, Y. (1989). Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels. Br. J.Pharmacol. 98: 1360–1364.
Kecskemeti V. and Braquet, P. (1992). Cellular electrophysiological effects of plateletactivating factor (PAF) and its antagonist BN 52921 in cardiac preparations. Drugs Exptl. Clin. Res. 18: 23–27.
Koltai, M., Hosford, D., Guinot, P., Esanu. A., and Braquet, P. (1991a). Plateletactivating factor (PAF): a review of its effects. antagonists and possible future clinical applications. Drugs 42 (Part I): 9–29.
Koltai, M., Hosford, D., Guinot, P., Esanu, A., and Braquet, P. (1991b). Plateletactivating factor (PAF): a review of its effects, antagonists and possible future clinical applications. Drugs 42 (Part II): 174–204.
Koltai, M., Tosaki, A., Guillon, J.-M., Hosford, D., and Braquet, P. (1989). PAF antagonists as potential therapeutic agents in cardiac anaphylaxis and myocardial ischemia. Cardiovasc. Drugs Rev. 7: 177–198.
Kuijpers, T.W., Hakkert, B.C., Hoogerwerf, M., Leeuwenberg J.F.M., and Roos,D.(1991). Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells: Endothelial Leukocyte adhesion molecule-1-mediated CD18 activation. J. Immunol. 147: 1369–1376.
Kunievsky, B. and Yavin, E. (1992). Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo. J.Pharmacol. Exp. Ther. 263: 562–568.
Lee, N.H. & Kerlavage, A.R. (1993). Molecular biology of G-protein-coupled receptors.D.N.&P. 6: 488–497.
Mazer, B.D., Domenico, J., Sawami, H., and Gelfand, E.W. (1991). Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human lymphoblastoid cells. J. Immunol. 146: 1914–1920.
Mazer, B.D., Sawami, H., Tordai, A., Gelfand, E.W. (1992). Platelet-activating factormediatedtransmembrane signaling in human B lymphocytes is regulated through a Pertussis-and Cholera toxin-sensitive pathway. J. Clin. Invest. 90: 759–765.
Miller, L.G., Bazan, N.G., Roy, R.B., Clostre, F., Gaver, A., and Braquet, P. (1991).Platelet activating factor antagonists interact with GABAA receptors. Res.Commun. Chem. Pathol. Pharmacol. 74: 253–256.
Maudsley, D.J. and Morris, A.G. (1987). Rapid intracellular calcium changes in U937 monocyte cell line: transient inncrease in response to platelet-activatng faactor aand chemotactic peptide but not interferon or lipopolysaccharide. Immunology 61: 189–194.
Moritoki, H., Hisayama, T., Takeuchi, S., Miyano, H., and Kondoh, W. (1992).Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br. J. Pharmacol. 107: 196–201.
Nakamura, M., Honda, Z., Waga, T., Matsumoto, T., Noma, M., and Shimizu, T.(1992). Endotoxin transduces Ca2+ signalling via platelet-activating factor receptor.FEBS-Lett. 314: 125–129.
Nussler, A.K., Di Silvio, M., Billiar, T.R., Hoffman, R.A., Geller, D.A., Selby, R.,Madariaga, J., and Simmons, R.L. (1992). Stimulation of nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261–264.
Paubert-Braquet, M., Hosford, D., Koltz, P., Guilbaud, J., and Braquet, P. (1991).Tumor necrosis factor primes PAF-induced superoxide production by human neutrophils: possible involvement of G proteins. J. Lipid Mediators 2: S1–S14.
Pedemonte, C.H. (1993). Structure-function relationship of membrane ion pumps.D.N.&P. 6: 498–507.
Prescott, S.M. Zimmerman, G.A., and McIntyre, T.M. (1990). Platelet-activating factor.J. Biol. Chem. 265: 1781–1784.
Rees, D.D., Palmer, R.M.J., Schulz, R., Hodson, H.F., and Moncada, S. (1990).Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746–752.
Rink, T.J. and Sage, S.O. (1990). Calcium signaling in human platelets. Annu. Rev.Physiol. 52: 431–446.
Schleiffenbaum, B. and Fehr, J. (1990). The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factorinduced neutrophil responses by receptor down-regulation. J. Clin. Invest.86:184–95.
Schulam, P.G., Putcha, G., Franklin-Johnson, J., and Schearer, W.T. (1990). Evidence for a platelet-activating factor receptor on human lymphoblastoid B cells activation of phosphoinositol cycle and induction of calcium mobilization. Biochem. Biophys.Res. Commun. 166: 1047–1052.
Shukla, S.D. and Hanahan, D.J. (1983). An early decrease in phosphatidylinositol 4,5biphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor). Arch. Biochem. Biophys. 227: 626–629.
Tateson, J.E., Moncada, S., and Vane, J.R. (1977). Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 13: 389–397.
Tseng, G.-N. and Hoffmann, B.F. (1989). Two components of transient outward current in canine ventricular myocytes. Circ. Res. 64: 633–647.
Van Willingen, G. and Akkerman, J.-W.N. (1991) Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets. Biochem. J. 273: 115–120.
Ward, S.G. and Westnick, J. (1988). Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U337 cells. Br. J. Pharmacol.93: 769–774.
Willard, A.L. (1992). Excitatory and neurotoxic actions of platelet-activating factor on rat myenteric neurons in cell culture. Ann. N. Y. Acad. Sci. 664: 284–292.
Yue, T.L., Gleason, M.M., Hallenbeck, J., and Feuerstein, G. (1991a). Characterization of platelet-activating factor-induced elevation of cytosolic free calcium level in neurohybrid NCB-20 cells. Neuroscience 41: 177–185.
Yue, T.L., Gu, J.L., and Feuerstein, G. (1992a). Protein kinase C activator phorbol 12, 13-dibutyrate inhibits platelet activating factor-stimulated Ca2+ mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells. Neurochem. Res. 17: 997–1004.
Yue, T.L., Stadel, J.M., Sarau, H.M., Friedman, E., Gu, J.L., Powers, D.A., Gleason, M.M., Feuerstein, G., and Wang, H.Y. (1992b). Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition of protein kinase C. Mol. Pharmacol. 41: 281–289.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Koltai, M., Hosford, D., Braquet, P.G. (1994). Platelet-Activating Factor and Calcium Signaling: Its Implication in Cellular Responses. In: Municio, A.M., Miras-Portugal, M.T. (eds) Cell Signal Transduction, Second Messengers, and Protein Phosphorylation in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1879-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1879-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5765-0
Online ISBN: 978-1-4615-1879-2
eBook Packages: Springer Book Archive